The following four probes cg19681793 (targeting THBS2), cg24215279 (targeting TPO), cg11235583 (targeting CLCNKB), and cg14158583 (targeting PVRL4) have also been confirmed to target effective genes with different methylation status in different IDH-dependent glioma subtypes. Here, IDH2 is linked to central nervous system cancer.